Rizzuto Carlo - Net Worth and Insider Trading

Rizzuto Carlo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rizzuto Carlo owns 3 companies in total, including Pandion Therapeutics Inc (PAND) , Graphite Bio Inc (GRPH) , and Century Therapeutics Inc (IPSC) .

Click here to see the complete history of Rizzuto Carlo’s form 4 insider trades.

Insider Ownership Summary of Rizzuto Carlo

Ticker	Comapny	Transaction Date	Type of Owner
PAND	Pandion Therapeutics Inc	2020-07-17	director
GRPH	Graphite Bio Inc	2021-06-24	director
IPSC	Century Therapeutics Inc	2022-06-09	director

Rizzuto Carlo Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Rizzuto Carlo Ownership Network

Ownership Network List of Rizzuto Carlo

No Data

Ownership Network Relation of Rizzuto Carlo

Rizzuto Carlo Owned Company Details

What does Pandion Therapeutics Inc do?

Who are the key executives at Pandion Therapeutics Inc?

Rizzuto Carlo is the director of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , See Remarks Joanne L. Viney , and 10 percent owner Mva Investors, Llc .

Pandion Therapeutics Inc (PAND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pandion Therapeutics Inc Insider Transactions

No Available Data

What does Graphite Bio Inc do?

Who are the key executives at Graphite Bio Inc?

Rizzuto Carlo is the director of Graphite Bio Inc. Other key executives at Graphite Bio Inc include 10 percent owner Ecor1 Capital, Llc , 10 percent owner Samsara Biocapital, L.p. , and CHIEF BUSINESS OFFICER Phil Gutry .

Graphite Bio Inc (GRPH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Graphite Bio Inc (GRPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Graphite Bio Inc (GRPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Graphite Bio Inc (GRPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Graphite Bio Inc Insider Transactions

No Available Data

What does Century Therapeutics Inc do?

Who are the key executives at Century Therapeutics Inc?

Rizzuto Carlo is the director of Century Therapeutics Inc. Other key executives at Century Therapeutics Inc include Chief Technology Officer Gregory Russotti , VP of Finance and Operations Douglas Carr , and Chief Operations Officer Adrienne Farid .

Century Therapeutics Inc (IPSC) Insider Trades Summary

Over the past 18 months, Rizzuto Carlo made no insider transaction in Century Therapeutics Inc (IPSC). Other recent insider transactions involving Century Therapeutics Inc (IPSC) include a net sale of 58,732 shares made by Adrienne Farid , a net sale of 15,000 shares made by Gregory Russotti , and a net sale of 1,457 shares made by Douglas Carr .

In summary, during the past 3 months, insiders sold 69,685 shares of Century Therapeutics Inc (IPSC) in total and bought 0 shares, with a net sale of 69,685 shares. During the past 18 months, 220,100 shares of Century Therapeutics Inc (IPSC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 220,100 shares.

Century Therapeutics Inc (IPSC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Century Therapeutics Inc Insider Transactions

No Available Data

Rizzuto Carlo Mailing Address

Above is the net worth, insider trading, and ownership report for Rizzuto Carlo. You might contact Rizzuto Carlo via mailing address: One Sansome Street, Suite 1650, San Francisco Ca 94104.

Discussions on Rizzuto Carlo

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.